Starodub & Greijmans Regulatory Consultancy B.V. announce a new strategic regulatory partnership

Author
Published on
Category
Updates

Starodub and Greijmans Regulatory Consultancy B.V. are excited to announce their strategic partnership to offer support for streamlining regulatory strategy and pathways for software products in the medical context.

This collaboration combines deep knowledge of regulatory pathways for software, used in healthcare in compliance with EU MDR, EU IVDR and EU AI Act. Together we will bring regulatory & operational excellence to accelerate the availability of innovative solutions for healthcare providers and their patients in Europe.

Explore Starodub updates

Your Product Might Be Safe. Is Your IFU?

EU drug-device combination products (DDC): regulatory aspects start early

Investing in ATMP or Biologics? Regulatory risk is value critical.

Valentyna Starodub
Founder and Chief Executive Officer
Valentyna Starodub

Let's Connect

Talk to an expert